Neurological disorders include Parkinson’s, epilepsy, chronic pain, tinnitus, Alzheimer’s, depression, headache, stroke, multiple sclerosis, brain injuries, neuro-infectious diseases, migraine, and other dementia. Neurological diseases accounted for 4.2% of the total number of diseases in 1996, which has increased to 6.29% in 2005, in terms of disability-adjusted life years. By 2030, this number is expected to reach 6.77%. According to the International Federation of Pharmaceuticals Manufacturers and Associations, the global burden of mental and neurological disorders is 13%, and its total contribution towards non-communicable diseases was estimated to be 30% by 2012.
Factors influencing the market demand of internal neurostimulation techniques are increased awareness of highly advanced and non-invasiveneurostimulation procedures, and sophisticated diagnostic techniques. Technological advancements made in the field of medical science, in addition to the widespread applicability of internal neurostimulation methods is expected to cause an upsurge in the overall demand of internal neurostimulation market.
This market research report offers in-depth profiling of key players, along with recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their market position. The report also offers a comprehensive overview of varied market dynamics, such as drivers, restraints, and upcoming opportunities.The global internal neurostimulation market is classified on the basis of type into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electric stimulation.